Recent Quotes (30 days)

You have no recent quotes
chg | %

RepliCel Life Sciences Inc  

(Public, CNSX:RP)   Watch this stock  
Find more results for RP
0.500
Dec 11 - Close
CNSX real-time data - Disclaimer
Currency in CAD
Range     -
52 week 0.00 - 0.55
Open     -
Vol. 0.00
Mkt cap     -
P/E     -
Div/yield     -
EPS 0.00
Shares     -
Beta     -
Inst. own     -
Nov 24, 2015
Q3 2015 RepliCel Life Sciences Inc Earnings Release (Estimated) Add to calendar
Aug 28, 2015
Q2 2015 RepliCel Life Sciences Inc Earnings Release
Aug 5, 2015
RepliCel Life Sciences Inc at CFA Society of Minnesota's InvestMNt Conference
  

Key stats and ratios

Q2 (Jun '15) 2014
Net profit margin - -
Operating margin - -
EBITD margin - -
Return on average assets -344.25% -247.92%
Return on average equity -566.11% -316.89%
Employees 4 -
CDP Score - -

Address

Suite 2020 - 401 West Georgia Street
VANCOUVER, BC V6B 5A1
Canada
+1-604-2488730 (Phone)
+1-604-2488690 (Fax)

Website links

Description

RepliCel Life Sciences Inc. is a regenerative medicine company focused on developing autologous cell therapies that treat functional cellular deficits. The diseases being addressed are chronic tendinosis, skin aging, and androgenetic alopecia (pattern baldness). Each disease state is consistent with a deficit of a specific cell type, which the Company believes is critical to normal function. All treatments under development are based on the Company's technology, which utilizes cells isolated from a patient's own healthy hair follicles. These products are built on the Company's manufacturing platforms and are covered by issued and filed patents, as well as trade secrets. The Company is also developing a programmable injector device designed for dermal injections of cells as currently approved dermal filler products.

Officers and directors

Peter K. Jensen Chairman of the Board
Age: 62
David M. Hall President, Chief Executive Officer, Director
Age: 59
Thomas A. Kordyback C.A. Chief Financial Officer
Age: 61
Brooke Hurford Director - Finance, Corporate Secretary
Kevin McElwee Ph.D. Chief Scientific Officer
Age: 43
Gemma Fetterley Vice President - Finance, Treasurer
Age: 35
Darrell Panich Vice President - Clinical Affairs
Age: 42
R. Lee Buckler Vice President, Vice President - Business and Corporate Development
Rolf Hoffmann M.D. Chief Medical Officer, Director
Age: 51
John Challis Director
Age: 66